Opinion: The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs
The FDA and FTC need to crack down on influencers advertising prescription drugs.
In June, the Food and Drug Administration issued a warning letter about advertisements for the drug Recorlev for Cushing’s syndrome — its first in more than a year about webpages that make “false or misleading claims” about prescription drugs. More recently, in December the agency published guidance about TV and radio advertisements.
But the FDA is behind on something crucial: It needs to develop and clarify regulations to protect patients from potential harm and misleading information on social media platforms, particularly from influencers.
What's Your Reaction?
